Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term “Bacterial/Fungal Cell Membranes and Proteins” is a highly generic designation referring collectively to the lipid bilayers and their associated proteins present in bacteria and fungi. These membranes are composed mainly of phospholipids, proteins (integral, peripheral, and lipid-anchored), and, in fungi, ergosterol. Membrane proteins mediate essential functions including molecular transport, cell wall biosynthesis, cell division, energy transduction, and interactions with host immunity. Both bacteria and fungi possess unique targets in their membranes and associated proteins that distinguish them from mammalian cells, making them primary sites of action for antibiotics (such as β-lactams and glycopeptides) and antifungals (such as azoles and echinocandins). Notable targets include penicillin-binding proteins in bacteria, β-barrel outer membrane proteins in Gram-negative bacteria, and β-1,3-glucan synthase in fungi. Safety concerns for membrane-targeting drugs include host toxicity and the potential for resistance development. Due to the vast diversity in protein and lipid composition among species and the lack of a single, specific molecular target, this term is not a canonical or standardized therapeutic target designation, and should be avoided in favor of specifying particular membrane proteins or enzymes of interest. Note: - The target name is overly broad and does not map to a unique molecule or standardized therapeutic target form. Precise drug targeting and scientific reporting require specific identification (e.g., “Penicillin-binding protein 2a,” “β-1,3-glucan synthase”) rather than generic references to entire membranes or their protein complements. - As such, is_incorrect: true, since the target comprises many distinct molecules with highly variable functions and roles in therapy, rather than a specific, actionable entity.
Inhibition of cell wall synthesis (e.g., PBPs, SEDS proteins, glucan synthases) Disruption of membrane integrity and permeability (e.g., polymyxins disrupt LPS in Gram-negatives, daptomycin disrupts membrane potential) Inhibition of ergosterol synthesis (in fungi; azoles) Inhibition of peptidoglycan crosslinking (β-lactams) Inhibition of β-glucan synthesis (echinocandins)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial or Fungal Cell Membrane Protein.